Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Mid Atlantic Retina is a premier ophthalmology practice specializing in diseases of the retina, macula, and vitreous, serving as the official Retina Service of Wills Eye Hospital. The group comprises internationally recognized physicians who provide advanced diagnostic and therapeutic services for conditions such as age-related macular degeneration, diabetic retinopathy, and retinal detachment. Beyond clinical care, the organization is a global leader in ophthalmic research, operating one of the largest clinical trial units in the world for retinal diseases. They collaborate extensively with pharmaceutical and biotech companies to evaluate novel therapies, including gene therapies and next-generation anti-VEGF agents. With numerous locations across Pennsylvania, New Jersey, and Delaware, Mid Atlantic Retina combines high-volume clinical expertise with cutting-edge academic research.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Mid-Atlantic Retina Consultations.